Literature DB >> 2200887

Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly.

S S Rhee1, E Hunter.   

Abstract

To obtain a better understanding of the role of the gag gene-encoded matrix (MA) protein in the assembly and maturation of type D retroviruses, we have made five mutants with specific in-frame deletions within the p10-coding region by the use of oligonucleotide-directed mutagenesis. The changes in the Gag polyprotein made by these mutations resulted in almost identical phenotypes. In cells expressing mutant genomes, the mutant Gag polyproteins were synthesized and modified with myristic acid in a normal manner. However, they were so unstable that the bulk of the newly synthesized polyproteins was degraded within 1 h without being processed into mature structural polypeptides. In contrast, wild-type polyproteins have a processing half-life of 3.0 to 3.5 h. The mutant Gag polyproteins were assembled with very low efficiency into capsids in the cytoplasm of the mutant-infected cells. Moreover, the few capsids that formed were neither released from nor accumulated in the cells. These results suggest that the matrix protein plays an important role in guiding the correct folding of the Gag polyprotein, which is presumably crucial for both stabilizing the molecule and facilitating the intermolecular interactions that occur during assembly of immature capsids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200887      PMCID: PMC247906     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Serological and biochemical characterization of the mouse mammary tumor virus with localization of p10.

Authors:  R D Cardiff; M J Puentes; L J Young; G H Smith; Y A Teramoto; B W Altrock; T S Pratt
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

2.  An analysis of type-C retrovirus polypeptides and their associations in the virion.

Authors:  R C Montelaro; S J Sullivan; D P Bolognesi
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

3.  Amino-terminal processing of proteins by N-myristoylation. Substrate specificity of N-myristoyl transferase.

Authors:  D A Towler; S R Eubanks; D S Towery; S P Adams; L Glaser
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

4.  Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.

Authors:  M V Nermut; H Frank; W Schäfer
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials.

Authors:  D L Fine; J C Landon; R J Pienta; M T Kubicek; M G Valerio; W F Loeb; H C Chopra
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

7.  Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Stromberg; N E Hurley; N L Davis; R R Rueckert; E Fleissner
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

10.  Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane.

Authors:  S S Rhee; H X Hui; E Hunter
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

View more
  42 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.

Authors:  Rabih Halwani; Ahmad Khorchid; Shan Cen; Lawrence Kleiman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.

Authors:  R J Owens; J W Dubay; E Hunter; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.

Authors:  J W Wills; R C Craven; R A Weldon; T D Nelle; C R Erdie
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

8.  Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  T Dorfman; F Mammano; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  The membrane-binding domain of the Rous sarcoma virus Gag protein.

Authors:  M F Verderame; T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.

Authors:  M Sakalian; S D Parker; R A Weldon; E Hunter
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.